10 Best “Strong Buy” Stocks — IPXL EA NSP and more

This week, these ten stocks, all currently earning A’s (“strong buy”) on Portfolio Grader, have the best year-to-date performance.

The price of Impax Laboratories, Inc. (IPXL) has seen a 51.4% boost since the first of the year. Impax Laboratories develops, manufactures, and markets both proprietary and multi-source pharmaceutical products utilizing its drug delivery technologies. For more information, get Portfolio Grader’s complete analysis of IPXL stock.

Since January 1, Electronic Arts (EA) has climbed 51.8%. Electronic Arts develops, publishes, and distributes branded interactive entertainment software worldwide for video game consoles, personal computers, handheld game players, and cellular handsets. For more information, get Portfolio Grader’s complete analysis of EA stock.

Shares of Insperity, Inc. (NSP) have leaped 53.1% since January 1. Insperity provides personnel management that encompasses a range of services, including benefits and payroll administration, health and workers’ compensation insurance programs and personnel records management. For more information, get Portfolio Grader’s complete analysis of NSP stock.

Since January 1, Stamps.com (STMP) has jumped 55.3%. Stamps.com is an Internet-based company that allows customers to send mail. For more information, get Portfolio Grader’s complete analysis of STMP stock.

Shares of China Biologic Products, Inc. (CBPO) have leaped 65.4% since January 1. China Biologic Products is a biopharmaceutical company that engages in the research, development, manufacture, and sale of human plasma-based biopharmaceutical products to hospitals and inoculation centers. For more information, get Portfolio Grader’s complete analysis of CBPO stock.

Since January 1, Ellie Mae, Inc. (ELLI) has shot up 74.4%. Ellie Mae provides business automation software for the mortgage industry in the United States. For more information, get Portfolio Grader’s complete analysis of ELLI stock.

The price of ABIOMED, Inc. (ABMD) is up 85.3% since the first of the year. Abiomed provides medical devices in circulatory support and it offers a continuum of care in heart recovery to acute heart failure patients. For more information, get Portfolio Grader’s complete analysis of ABMD stock.

The price of Ebix, Inc. (EBIX) has seen a 95.2% boost since the first of the year. Ebix provides a series of application software products for the insurance industry, including carrier systems and agency systems. For more information, get Portfolio Grader’s complete analysis of EBIX stock.

Since January 1, the price of Skechers U.S.A., Inc. Class A (SKX) has grown 110.4%. Skechers USA designs, makes, markets and distributes footwear. For more information, get Portfolio Grader’s complete analysis of SKX stock.

Shares of Chimera Investment Corporation (CIM) have risen 317.6% since January 1. Chimera Investment is a specialty finance company that invests in residential mortgage-backed securities, residential mortgage loans, real estate-related securities, and various other asset classes. The stock’s trailing PE Ratio is 5.30. For more information, get Portfolio Grader’s complete analysis of CIM stock.

Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.


Article printed from InvestorPlace Media, https://investorplace.com/2015/07/10-best-strong-buy-stocks-ipxl-ea-nsp-and-more-ipxl-ea-nsp/.

©2022 InvestorPlace Media, LLC